Search from 500+ procedures across top NABH & JCI accredited hospitals of India
Medical Visa
Assistance
Assistance
Tele-Video
Consultation
Consultation
Language Interpretation
Services
Services
Second Medical
Opinion
Opinion
Post-Treatment
Care Coordination
Care Coordination
Coordinating care at accredited hospitals, including
Apollo HospitalsFortis HealthcareManipal HospitalsSarvodaya Hospital
Not sure where to start? Get a free medical opinion Not sure what your treatment will cost? Free, instant, itemised estimate -- treatment, visa, flights, hotel & food
What will your treatment cost?
Satyug Assistant
Online · usually replies instantly
Answers are informational, not medical advice.
Dr. Suhas Singla [MBBS, MD (Nuclear Medicine)]
🌍 International Patient Helpdesk
+91-8860606766 | +91-9910655125About Dr. Suhas Singla [MBBS, MD (Nuclear Medicine)]
Dr. Suhas Singla is Nuclear Medicine Specialist and Currently Working as Director in the Nuclear Medicine Department at Medanta Hospital, Sector 50, Noida, India.
He is having more than 18 years of experience in the field of nuclear medicine.
He has completed his MBBS from UCMS and GTB Hospital, Delhi, and MD from the All India Institute of Medical Sciences (AIIMS), New Delhi.
Profile Highlights :
- Dr. Singla trained at AIIMS, New Delhi, and is skilled in both diagnostic and therapeutic applications of nuclear medicine. During his time at AIIMS he worked under Prof. C.S. Bal and was part of the team that initiated 177Lu-DOTATATE therapy for the first time in India in 2007, a landmark in the development of targeted radionuclide therapy in the country.
- He later introduced 177Lu-PSMA and 177Lu-DOTATATE therapy in Noida. 177Lu-DOTATATE is a peptide receptor radionuclide therapy used for unresectable or metastatic neuroendocrine tumours, while 177Lu-PSMA therapy delivers targeted radiation to cells expressing prostate-specific membrane antigen in advanced castrate-resistant prostate cancer.
- His diagnostic expertise covers PET-CT and SPECT-CT, including oncological imaging with FDG, PSMA, DOPA, Choline and NOTA PET-CT tracers, as well as the full range of SPECT-CT procedures. These studies help to detect cancer, stage it accurately, assess response to treatment and select patients who are suitable for theranostic therapy.
- Dr. Singla has more than 14 international publications to his credit. He works closely with oncologists, urologists and surgeons to integrate molecular imaging and targeted radionuclide therapy into each patient's overall cancer treatment plan.
Areas of Expertise :
- PET-CT and SPECT-CT Imaging
- Oncological PET Imaging
- 177Lu-DOTATATE Therapy
- 177Lu-PSMA Therapy
- Theranostics
- PET-CT Scan
- SPECT-CT Scan
- FDG PET-CT for Cancer Staging
- PSMA PET-CT for Prostate Cancer
- DOPA PET-CT
- Choline PET-CT
- NOTA / DOTA PET-CT for Neuroendocrine Tumours
- 177Lu-DOTATATE Therapy for Neuroendocrine Tumours
- 177Lu-PSMA Therapy for Prostate Cancer
List of Treatments
- PET-CT Scan
- SPECT-CT Scan
- FDG PET-CT for Cancer Staging
- PSMA PET-CT for Prostate Cancer
- DOPA PET-CT
- Choline PET-CT
- NOTA / DOTA PET-CT for Neuroendocrine Tumours
- 177Lu-DOTATATE Therapy for Neuroendocrine Tumours
- 177Lu-PSMA Therapy for Prostate Cancer
- Bone Scan
- Thyroid Scan and Radioiodine Therapy
- Renal and Cardiac Nuclear Scans
Work Experience
Currently Working as Director in the Nuclear Medicine Department at Medanta Hospital, Sector 50, Noida, India.
Past Experience :
- Nuclear Medicine - All India Institute of Medical Sciences (AIIMS), New Delhi
Education & Training
- MBBS - UCMS and GTB Hospital, Delhi
- MD - All India Institute of Medical Sciences (AIIMS), New Delhi
Awards & Recognition
- Part of the team that initiated 177Lu-DOTATATE therapy for the first time in India (2007)
- Introduced 177Lu-PSMA and 177Lu-DOTATATE therapy in Noida
- More than 14 international publications
Associated Hospitals
🏨 Medanta Hospital, Noida
Location
📌
Medanta Hospital, Sector 50, Noida, India
Frequently Asked Questions
Where does Dr. Suhas Singla practice?
Dr. Suhas Singla practises as Director in the Nuclear Medicine Department at Medanta Hospital, Sector 50, Noida, India.
What does Dr. Suhas Singla specialise in?
He specialises in PET-CT and SPECT-CT imaging and in targeted radionuclide therapies such as 177Lu-DOTATATE for neuroendocrine tumours and 177Lu-PSMA for advanced prostate cancer.
How much experience does Dr. Suhas Singla have?
Dr. Singla has more than 18 years of experience in nuclear medicine and was part of the AIIMS team that started 177Lu-DOTATATE therapy in India in 2007.
👨⚕️Similar Doctors
🏥 Top Hospitals
.webp)
HAPPY PATIENTS
What Our Patients Are Saying
Our Gallery
